1. Home
  2. QLGN vs VLCN Comparison

QLGN vs VLCN Comparison

Compare QLGN & VLCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QLGN
  • VLCN
  • Stock Information
  • Founded
  • QLGN 1996
  • VLCN 2020
  • Country
  • QLGN United States
  • VLCN United States
  • Employees
  • QLGN N/A
  • VLCN N/A
  • Industry
  • QLGN Biotechnology: Pharmaceutical Preparations
  • VLCN Auto Manufacturing
  • Sector
  • QLGN Health Care
  • VLCN Consumer Discretionary
  • Exchange
  • QLGN Nasdaq
  • VLCN Nasdaq
  • Market Cap
  • QLGN 3.2M
  • VLCN 2.6M
  • IPO Year
  • QLGN N/A
  • VLCN 2021
  • Fundamental
  • Price
  • QLGN $4.07
  • VLCN $3.76
  • Analyst Decision
  • QLGN
  • VLCN
  • Analyst Count
  • QLGN 0
  • VLCN 0
  • Target Price
  • QLGN N/A
  • VLCN N/A
  • AVG Volume (30 Days)
  • QLGN 20.7K
  • VLCN 29.5K
  • Earning Date
  • QLGN 11-14-2024
  • VLCN 11-12-2024
  • Dividend Yield
  • QLGN N/A
  • VLCN N/A
  • EPS Growth
  • QLGN N/A
  • VLCN N/A
  • EPS
  • QLGN N/A
  • VLCN N/A
  • Revenue
  • QLGN N/A
  • VLCN $4,134,075.00
  • Revenue This Year
  • QLGN N/A
  • VLCN $339.16
  • Revenue Next Year
  • QLGN N/A
  • VLCN N/A
  • P/E Ratio
  • QLGN N/A
  • VLCN N/A
  • Revenue Growth
  • QLGN N/A
  • VLCN 41.15
  • 52 Week Low
  • QLGN $3.34
  • VLCN $3.49
  • 52 Week High
  • QLGN $29.45
  • VLCN $5,904.00
  • Technical
  • Relative Strength Index (RSI)
  • QLGN 45.00
  • VLCN 39.18
  • Support Level
  • QLGN $3.95
  • VLCN $3.52
  • Resistance Level
  • QLGN $4.21
  • VLCN $3.98
  • Average True Range (ATR)
  • QLGN 0.27
  • VLCN 0.35
  • MACD
  • QLGN 0.00
  • VLCN -0.00
  • Stochastic Oscillator
  • QLGN 22.08
  • VLCN 18.75

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.

About VLCN Volcon Inc. Common stock

Volcon Inc is an all-electric, off-road powersports vehicle company developing and building electric two and four-wheel motorcycles and utility terrain vehicles, also known as side-by-sides, along with a complete line of upgrades and accessories. The company's products include motorcycle and UTV products that are all-electric and designed for off-road use. The company has hundred and three dealers covering twenty eight states.

Share on Social Networks: